31 – 40 of 82
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.
(
- Contribution to journal › Article
-
Mark
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.
(
- Contribution to journal › Article
-
Mark
Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
(
- Contribution to journal › Article
-
Mark
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma
(
- Contribution to journal › Article
-
Mark
CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
(
- Contribution to journal › Article
-
Mark
MITF Modulates Therapeutic Resistance through EGFR Signaling.
(
- Contribution to journal › Article
-
Mark
BAP1 Plays a Survival Role in Cutaneous Melanoma.
(
- Contribution to journal › Article
-
Mark
Nonsense Mutations in the Shelterin Complex Genes ACD and TERF2IP in Familial Melanoma.
(
- Contribution to journal › Article
-
Mark
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma
(
- Contribution to journal › Article